Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Pfizer
OncoNano Medicine, Inc.
Washington University School of Medicine
Tempus AI
Lund University Hospital
Cedars-Sinai Medical Center
Checkpoint Therapeutics, Inc.
VitaMed Research LLC
Genmab
Genmab
Celgene
Stanford University
Central Hospital, Nancy, France
Case Comprehensive Cancer Center
sigma-tau i.f.r. S.p.A.
Stanford University
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Netherlands Open University
NIH AIDS Clinical Trials Information Service